A New Anthrax Vaccine Administered by the Intramuscular (IM) Route in Healthy Adults
Clinical trial NCT00057525 · COMPLETED
Trial details
- NCT number
- NCT00057525
- Sponsor
- DynPort Vaccine Company LLC, A GDIT Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
- Primary completion
- 2004-04-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.